A single-institution experience with bevacizumab in the treatment of metastatic colorectal cancer and in conjunction with liver resection

BACKGROUND: Bevacizumab is active in the treatment of metastatic colorectal cancer (mCRC). However, efficacy of bevacizumab has predominantly been evaluated on selected patients with relatively good performance status and minor comorbidities. We evaluated the efficacy and safety of bevacizumab in un...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Osterlund, Pia, Peltonen, Reetta, Alanko, Tuomo, Bono, Petri, Isoniemi, Helena
Formato: Artigo
Idioma:Inglês
Publicado: Dove Medical Press 2014
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4085307/
https://ncbi.nlm.nih.gov/pubmed/25061319
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S63739
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares